Rhythm Pharmaceuticals (RYTM) Profit After Tax (2016 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Profit After Tax came in at -$55.6 million in Q1 2026, down 9.46% year-on-year from -$61.5 million in Q1 2025, and down 17.12% on a QoQ basis from -$47.5 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Profit After Tax (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 11 years of Profit After Tax data on file, last reported at -$55.6 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 9.46% year-over-year to -$55.6 million in Q1 2026; TTM through Mar 2026 was -$202.7 million, a 19.21% decrease from a year earlier, with the FY2025 full-year figure at -$196.5 million, up 24.58% from the prior year.
- Profit After Tax for Q1 2026 stood at -$55.6 million, down from -$47.5 million in the prior quarter.
- Over the last five years, Profit After Tax for RYTM reached as high as -$32.3 million in Q2 2024 and fell as low as -$141.4 million in Q1 2024.
- Historically, Profit After Tax has averaged -$51.8 million across 5 years, with a median of -$46.6 million in 2025.
- Across the five-year window, Profit After Tax tumbled 220.6% in 2022 and surged 64.04% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$42.5 million in 2022, then advanced by 2.02% to -$41.6 million in 2023, then slipped by 3.98% to -$43.3 million in 2024, then dropped by 9.73% to -$47.5 million in 2025, then decreased by 17.12% to -$55.6 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$55.6 million in Q1 2026, -$47.5 million in Q4 2025, and -$52.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn | -55.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.64 Mn |
| Dec 31, 2025 | -47.51 Mn |
| Sep 30, 2025 | -52.90 Mn |
| Jun 30, 2025 | -46.63 Mn |
| Mar 31, 2025 | -50.83 Mn |
| Dec 31, 2024 | -43.29 Mn |
| Sep 30, 2024 | -43.64 Mn |
| Jun 30, 2024 | -32.26 Mn |
| Mar 31, 2024 | -141.37 Mn |
| Dec 31, 2023 | -41.63 Mn |
| Sep 30, 2023 | -44.16 Mn |
| Jun 30, 2023 | -46.70 Mn |
| Mar 31, 2023 | -52.18 Mn |
| Dec 31, 2022 | -42.49 Mn |
| Sep 30, 2022 | -40.86 Mn |
| Jun 30, 2022 | -45.00 Mn |
| Mar 31, 2022 | -52.76 Mn |
| Dec 31, 2021 | -42.87 Mn |
| Sep 30, 2021 | -35.11 Mn |
| Jun 30, 2021 | -35.39 Mn |